Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 2Uveal Melanoma 1Smoking Cessation 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Multiple Myeloma 1Motor Activity 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Inflammation 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Oxaliplatin 146Fluorouracil 137Capecitabine 122Leucovorin 106Irinotecan 85Radiotherapy 67Bevacizumab 64Cetuximab 46Folfox protocol 28Surgical Procedures, Operative 23Radiation 23Drug Therapy 22Panitumumab 19XELOX 18Chemotherapy, Adjuvant 15Neoadjuvant Therapy 14Radiotherapy, Intensity-Modulated 13Chemoradiotherapy 13Magnetic Resonance Spectroscopy 11regorafenib 10Nivolumab 10Floxuridine 10sintilimab 8raltitrexed 8Specimen Handling 8IFL protocol 8Celecoxib 8Biopsy 8trifluridine tipiracil drug combination 7tislelizumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Rectal Neoplasms × Diet Therapy × Clear all
NCT04205955 2024-05-01

Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors

SWOG Cancer Research Network

Phase 2 Completed
95 enrolled 30 charts
Gastrointestinal

Rectal Neoplasms

NCT03781778 2022-10-06

Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors

Fred Hutchinson Cancer Center

Phase 2 Terminated
10 enrolled 15 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡